Bacterial disease

Death rates for the hydrocortisone group was not significantly lower than the placebo group; a total of 511 patients (27.9%) in the hydrocortisone group died compared to 526 (28.8%) in the placebo group (odds ratio, 0.85; 85% CI, 0.82 to 1.10; P=0.50).

The latest Vital Signs report from the Centers for Disease Control and Prevention (CDC) emphasizes the need for healthcare workers to use a combination of infection control recommendations to protect patients against antibiotic-resistant bacteria.